Skip to main content
Skip to footer
Firm
Our team
Join us
Expertise
Expertise
Patents
UPC
FRAND and SEPs
Pharma and SPCs
Trade secrets
Saisie-contrefaçon
Contracts
Patent valuation
Employee inventions
All fields of expertise
Services
Patent litigation
Bringing an infringement action
Infringement defence
Invalidity action
Provisional measures
Evidence before the UPC
The FRAND undertaking
Arbitration and mediation
Advice:
Second opinion
Litigation readiness
Saisie-contrefaçon preparedness
Trade secret audit
IP due diligence
Local counsel in France
Japan and Europe
Defensible portfolio
Litigation funding
All services
Technologies
Technical fields
Electronics
Telecoms and FRAND
Pharmaceuticals
Medical devices
Chemistry
Biotechnology
Mechanical engineering
Publications
Blog
Kluwer Patent Blog
Journals and books
Speaking engagements
Patent litigation news
Consultation responses
Glossary
All publications
Le Lab
UPC Litigation Watch
UPC decisions analysed
UPC statistics
FRAND Litigation Watch
FRAND decisions analysed
Pharma Litigation Watch
Pharma decisions analysed
Subscribe to the watch
Contact
fr
en
ja
Back to blog
Category : Sufficiency of the description
23 October 2026
Biogaran v. Lundbeck and the Challenger’s Burden in Second Medical Use Cases
23 October 2026
Biogaran v. Lundbeck and the Challenger’s Burden in Second Medical Use Cases
Patents
Litigation
UPC
Pharmaceuticals
Sufficiency of disclosure
